Study details
Enrolling now
VALOROUS Trial
University of California, Davis
NCT IDNCT06103669ClinicalTrials.gov data as of Apr 2026
Target enrollment
250
Study length
about 7.3 years
Ages
18+
Locations
1 site in CA
What this study is about
This trial is testing a treatment called locally ablative therapy for people with oligo-progressive solid tumors. The goal is to see if adding this treatment to ongoing systemic therapy helps patients stay stable longer.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Ablative local therapy
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Median overall survival, Number of participants experiencing grade ≥ 3 adverse events attributable to ablative local therapy, Time to treatment failure
Body systems
Oncology